170 related articles for article (PubMed ID: 38299254)
21. The arginine methyltransferase PRMT6 regulates cell proliferation and senescence through transcriptional repression of tumor suppressor genes.
Stein C; Riedl S; Rüthnick D; Nötzold RR; Bauer UM
Nucleic Acids Res; 2012 Oct; 40(19):9522-33. PubMed ID: 22904088
[TBL] [Abstract][Full Text] [Related]
22. PELP1 oncogenic functions involve alternative splicing via PRMT6.
Mann M; Zou Y; Chen Y; Brann D; Vadlamudi R
Mol Oncol; 2014 Mar; 8(2):389-400. PubMed ID: 24447537
[TBL] [Abstract][Full Text] [Related]
23. Protein arginine methyltransferase 6-dependent gene expression and splicing: association with breast cancer outcomes.
Dowhan DH; Harrison MJ; Eriksson NA; Bailey P; Pearen MA; Fuller PJ; Funder JW; Simpson ER; Leedman PJ; Tilley WD; Brown MA; Clarke CL; Muscat GE
Endocr Relat Cancer; 2012 Aug; 19(4):509-26. PubMed ID: 22673335
[TBL] [Abstract][Full Text] [Related]
24. Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive.
Guccione E; Bassi C; Casadio F; Martinato F; Cesaroni M; Schuchlautz H; Lüscher B; Amati B
Nature; 2007 Oct; 449(7164):933-7. PubMed ID: 17898714
[TBL] [Abstract][Full Text] [Related]
25. Protein arginine methyltransferase 6 mediates cardiac hypertrophy by differential regulation of histone H3 arginine methylation.
Raveendran VV; Al-Haffar K; Kunhi M; Belhaj K; Al-Habeeb W; Al-Buraiki J; Eyjolsson A; Poizat C
Heliyon; 2020 May; 6(5):e03864. PubMed ID: 32420474
[TBL] [Abstract][Full Text] [Related]
26. PRMT6-CDC20 facilitates glioblastoma progression via the degradation of CDKN1B.
Wang J; Xiao Z; Li P; Wu C; Li Y; Wang Q; Chen Y; Zhou H; Li Z; Wang Z; Lan Q; Wang Y
Oncogene; 2023 Mar; 42(14):1088-1100. PubMed ID: 36792756
[TBL] [Abstract][Full Text] [Related]
27. PRMT6 methylation of STAT3 regulates tumor metastasis in breast cancer.
Chen Q; Hu Q; Chen Y; Shen N; Zhang N; Li A; Li L; Li J
Cell Death Dis; 2023 Oct; 14(10):655. PubMed ID: 37813837
[TBL] [Abstract][Full Text] [Related]
28. The protective effect of PRMT6 overexpression on cigarette smoke extract-induced murine emphysema model.
He X; Li T; Kang N; Zeng H; Ren S; Zong D; Li J; Cai S; Chen P; Chen Y
Int J Chron Obstruct Pulmon Dis; 2017; 12():3245-3254. PubMed ID: 29138553
[TBL] [Abstract][Full Text] [Related]
29. Cell cycle regulation by the PRMT6 arginine methyltransferase through repression of cyclin-dependent kinase inhibitors.
Kleinschmidt MA; de Graaf P; van Teeffelen HA; Timmers HT
PLoS One; 2012; 7(8):e41446. PubMed ID: 22916108
[TBL] [Abstract][Full Text] [Related]
30. SCF-FBXO24 regulates cell proliferation by mediating ubiquitination and degradation of PRMT6.
Chen W; Gao D; Xie L; Wang A; Zhao H; Guo C; Sun Y; Nie Y; Hong A; Xiong S
Biochem Biophys Res Commun; 2020 Sep; 530(1):75-81. PubMed ID: 32828318
[TBL] [Abstract][Full Text] [Related]
31. A gain-of-function mouse model identifies PRMT6 as a NF-κB coactivator.
Di Lorenzo A; Yang Y; Macaluso M; Bedford MT
Nucleic Acids Res; 2014 Jul; 42(13):8297-309. PubMed ID: 24939901
[TBL] [Abstract][Full Text] [Related]
32. Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers.
Yoshimatsu M; Toyokawa G; Hayami S; Unoki M; Tsunoda T; Field HI; Kelly JD; Neal DE; Maehara Y; Ponder BA; Nakamura Y; Hamamoto R
Int J Cancer; 2011 Feb; 128(3):562-73. PubMed ID: 20473859
[TBL] [Abstract][Full Text] [Related]
33. Protein arginine methyltransferase 6 controls erythroid gene expression and differentiation of human CD34
Herkt SC; Kuvardina ON; Herglotz J; Schneider L; Meyer A; Pommerenke C; Salinas-Riester G; Seifried E; Bonig H; Lausen J
Haematologica; 2018 Jan; 103(1):18-29. PubMed ID: 29025910
[TBL] [Abstract][Full Text] [Related]
34. Automethylation of protein arginine methyltransferase 6 (PRMT6) regulates its stability and its anti-HIV-1 activity.
Singhroy DN; Mesplède T; Sabbah A; Quashie PK; Falgueyret JP; Wainberg MA
Retrovirology; 2013 Jul; 10():73. PubMed ID: 23866860
[TBL] [Abstract][Full Text] [Related]
35. Significant association of PRMT6 hypomethylation with colorectal cancer.
Pan R; Yu H; Dai J; Zhou C; Ying X; Zhong J; Zhao J; Zhang Y; Wu B; Mao Y; Wu D; Ying J; Duan S
J Clin Lab Anal; 2018 Nov; 32(9):e22590. PubMed ID: 29927001
[TBL] [Abstract][Full Text] [Related]
36. Protein arginine methyltransferase 6 suppresses adipogenic differentiation by repressing peroxisome proliferator‑activated receptor γ activity.
Hwang JW; So YS; Bae GU; Kim SN; Kim YK
Int J Mol Med; 2019 Jun; 43(6):2462-2470. PubMed ID: 30942395
[TBL] [Abstract][Full Text] [Related]
37. Systematic investigation of PRMT6 substrate recognition reveals broad specificity with a preference for an RG motif or basic and bulky residues.
Hamey JJ; Rakow S; Bouchard C; Senst JM; Kolb P; Bauer UM; Wilkins MR; Hart-Smith G
FEBS J; 2021 Oct; 288(19):5668-5691. PubMed ID: 33764612
[TBL] [Abstract][Full Text] [Related]
38. PRMT6 deficiency induces autophagy in hostile microenvironments of hepatocellular carcinoma tumors by regulating BAG5-associated HSC70 stability.
Che N; Ng KY; Wong TL; Tong M; Kau PW; Chan LH; Lee TK; Huen MS; Yun JP; Ma S
Cancer Lett; 2021 Mar; 501():247-262. PubMed ID: 33186656
[TBL] [Abstract][Full Text] [Related]
39. MiR-141-3p promotes malignant progression in prostate cancer through AlkB homolog 5-mediated m
Li X; Liu B; Wang S; Li J; Ge X
Chin J Physiol; 2023; 66(1):43-51. PubMed ID: 36814156
[TBL] [Abstract][Full Text] [Related]
40. Protein arginine methyltransferase 6 regulates multiple aspects of gene expression.
Harrison MJ; Tang YH; Dowhan DH
Nucleic Acids Res; 2010 Apr; 38(7):2201-16. PubMed ID: 20047962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]